top of page
![](https://static.wixstatic.com/media/nsplsh_30744e465f6d486d5f4c73~mv2_d_5038_2967_s_4_2.jpg/v1/fill/w_288,h_170,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/nsplsh_30744e465f6d486d5f4c73~mv2_d_5038_2967_s_4_2.jpg)
RiboFlare
Dr. Nikravesh joins RiboFlare as EVP & Senior VP.
Riboflare, Inc. (Nevada Corp) is a point-of-care Company for on-site clinical diagnostics targeting infectious disease, oral microbiome, gut microbiome, and bio-threat. Ribbflare provides predictive models of disease progression including diabetes, cancer, and inflammatory bowel disease to name a few. Riboflare technology is based on patented innovative nano-particles and microfluid systems-based technologies. This cutting edge technologies enable our innovative solution for microbiome molecular imaging based on multiplexed live cell assay such as oral microbiome and infectious disease.
![](https://static.wixstatic.com/media/925842_c626e5573bb34b738b7a20c6c33030eb.jpg/v1/fill/w_968,h_499,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/925842_c626e5573bb34b738b7a20c6c33030eb.jpg)
bottom of page